These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 909903)

  • 1. [Synthesis and testing of potential antiparkinson agents. 2. Biologically active silicium derivatives].
    Friedrich G; Bartsch R; Rühlmann K
    Pharmazie; 1977 Jul; 32(7):394-7. PubMed ID: 909903
    [No Abstract]   [Full Text] [Related]  

  • 2. [Synthesis and testing of potential anti-parkinson agents. 3: Biologically active silicon compounds].
    Krebs R; Bartsch R; Rühlmann K
    Pharmazie; 1982 Jul; 37(7):483-4. PubMed ID: 7134253
    [No Abstract]   [Full Text] [Related]  

  • 3. [1-(p-carboalkoxyphenoxy) silatranes].
    Lukasiak J; Radecki A; Jamrógiewicz Z; Wrześniowska K
    Acta Pol Pharm; 1976; 33(2):177-82. PubMed ID: 937021
    [No Abstract]   [Full Text] [Related]  

  • 4. O-methylated catechol metabolites of 3-(3-hydroxy-phenyl)-N-propyl piperidine (3-PPP): synthesis, pharmacological and acute toxicological evaluation.
    Thorberg SO; Ahlénius S; Johansson L; Lundström J; Säfholm C; Teiling A; Lennmark M
    Acta Pharm Suec; 1987; 24(4):183-92. PubMed ID: 3439467
    [No Abstract]   [Full Text] [Related]  

  • 5. (+/-)-1-(Adamantan-2-yl)-2-propanamine and other amines derived from 2-adamantanone.
    Mariani E; Schenone P; Bondavalli F; Lampa E; Marmo E
    Farmaco Sci; 1980 May; 35(5):430-40. PubMed ID: 7192647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deoxyribonucleoside-3',5'-cyclic silanediyl derivatives: formation and properties.
    Furusawa K; Katsura T; Sakai T; Tsuda K
    Nucleic Acids Symp Ser; 1984; (15):41-4. PubMed ID: 6522290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substituted dopamine quinazolones as potent antiparkinsonian agents.
    Kumar P; Agarwal JC; Nath C; Bhargava KP; Shanker K
    Pharmazie; 1981 Nov; 36(11):780. PubMed ID: 7323128
    [No Abstract]   [Full Text] [Related]  

  • 8. [Epidemic tremor in chickens as a model for the testing of antiparkinson drugs].
    Stern P; Srebocan S; Cvetnić S; Brmalj V
    Acta Biol Med Ger; 1973; 31(3):463-5. PubMed ID: 4775352
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and antiparkinsonian activity of styryl quinazolones.
    Kumar P; Nath C; Bhargava KP; Shanker K
    Pharmazie; 1982 Nov; 37(11):802. PubMed ID: 7163366
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and biological activity of D3-trishomocubyl-4-amines.
    Oliver DW; Dekker TG; Snyckers FO; Fourie TG
    J Med Chem; 1991 Feb; 34(2):851-4. PubMed ID: 1995908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathophysiology of static tremor in Parkinsonism].
    Stern P; Catović S
    Neuropsihijatrija; 1964; 12(1-4):7-10. PubMed ID: 16305149
    [No Abstract]   [Full Text] [Related]  

  • 12. Some novel organosilanes as potent anti-tubercular agents.
    Srivastava VK; Kumar P; Agarwal JC; Vrat S; Dhawan KN; Shanker K
    Pharmazie; 1981 Jun; 36(6):441. PubMed ID: 6792633
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological & biochemical characterization of antiparkinson drugs in reserpinized mice.
    David J; Kaul CL; Grewal RS
    Indian J Exp Biol; 1979 Aug; 17(8):760-4. PubMed ID: 575644
    [No Abstract]   [Full Text] [Related]  

  • 14. 1-[4-(4,5-dihydro-1H-imidazol-2-yl)aminophenyl]-3-(substituted phenyl)-2-propene-1-one as antiparkinsonian agents.
    Srivastava VK; Singh S; Palit G; Shanker K
    Pharmazie; 1986 Aug; 41(8):598-9. PubMed ID: 3786386
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bicyclic analogs of piperazine. XII. (1) - Synthesis of 3,8-diazabicyclo/3,2,1/octanes as potential antiparkinson agents].
    Occelli E; Fontanella L; Testa E
    Farmaco Sci; 1977 Apr; 32(4):237-47. PubMed ID: 862878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The evaluation of the specific activity and side effects of the m-cholinergic blocker pentifin compared to other antiparkinson agents].
    Khrabrova AV; Zagrebin AO; Kosmachev AB; Kubarskaia LG; Lychakov AV; Libman NM; Savateeva TN; Titkova TA; Tonkopiĭ VD; Fil'ko OA; Khobotova ZI
    Eksp Klin Farmakol; 2000; 63(2):21-3. PubMed ID: 10834089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of some substituted-1,2,4-triazino[5,6-b]indole derivatives as potential antiviral and anticancer agents.
    Eshba NH; Salama HM; Labouta IM; Omar AM
    Pharmazie; 1987 Oct; 42(10):664-6. PubMed ID: 3438319
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antiviral chemotherapeutic agents. XVIII. Adamantane derivatives of amphetamine. Their potential interest as autonomic and antiparkinson agents].
    Runti C; De Nardo M; Fabrissin S
    Farmaco Sci; 1975 Apr; 30(4):260-75. PubMed ID: 241665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The antiparkinson activity of a new adamantane derivative].
    Val'dman EA; Voronina TA; Nerobkova LN
    Eksp Klin Farmakol; 1999; 62(4):3-6. PubMed ID: 10513325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis and properties of 7-styrylimidazo[1,2-c] pyrimidine derivatives].
    Długosz A; Machoń Z
    Acta Pol Pharm; 1988; 45(1):26-30. PubMed ID: 3421138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.